Page last updated: 2024-11-01

ofloxacin and Haim-Monk Syndrome

ofloxacin has been researched along with Haim-Monk Syndrome in 2 studies

Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishikawa, I2
Umeda, M2
Laosrisin, N1
Zhang, YJ1
Koseki, T1

Other Studies

2 other studies available for ofloxacin and Haim-Monk Syndrome

ArticleYear
Clinical, bacteriological, and immunological examinations and the treatment process of two Papillon-Lefèvre syndrome patients.
    Journal of periodontology, 1994, Volume: 65, Issue:4

    Topics: Aggregatibacter actinomycetemcomitans; Alveolar Bone Loss; Child; Child, Preschool; Colony Count, Mi

1994
[Clinical, bacteriological, and immunological examination and treatment of two Papillon-Lefevre syndrome patients].
    Kokubyo Gakkai zasshi. The Journal of the Stomatological Society, Japan, 1990, Volume: 57, Issue:3

    Topics: Actinobacillus; Actinobacillus Infections; Antibodies, Bacterial; Child; Child, Preschool; Enzyme-Li

1990